Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 11/20 | 0.40 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | PKM | P14618 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.34 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.34 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CCR10 | P46092 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4203691 | 0.89 | TSHR (0.41) | ADORA2ALMNAHTTTSHRKMT2A | |
| SCHEMBL4196148 | 0.87 | ADORA2A (0.38) | ADORA2ALMNAHTTTSHRKMT2A | |
| SCHEMBL4199465 | 0.86 | ADORA2A (0.39) | ADORA2ALMNAHTTTSHRKMT2A | |
| SCHEMBL4197196 | 0.85 | ADORA2A (0.36) | ADORA2ALMNAHTTTSHRKMT2A | |
| SCHEMBL4189045 | 0.81 | ADORA2A (0.38) | ADORA2ALMNAHTTTSHRKMT2A | |
| SCHEMBL4205202 | 0.81 | ADORA2A (0.35) | ADORA2ALMNATSHRKMT2AMEN1 | |
| SCHEMBL4195359 | 0.76 | ADORA2A (0.40) | ADORA2ALMNAHTTADORA3ADORA2B | |
| SCHEMBL4205235 | 0.75 | SMN1; SMN2 (0.37) | LMNAHTTTSHRKMT2AMEN1 | |
| SCHEMBL4192247 | 0.73 | TRPV1 (0.34) | LMNATSHRKMT2AMEN1PKM | |
| SCHEMBL4199246 | 0.72 | ADORA2A (0.39) | ADORA2ALMNAHTTADORA3ADORA2B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090042917-A1 | Aminopyrimidine Derivative and Plant Disease Control Agent for Agricultural or Horticultural Use | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2009-02-12 | — | — | US | disclosed |
| EP-2006288-A1 | AMINOPYRIDINE DERIVATIVE AND PLANT DISEASE CONTROL AGENT FOR AGRICULTURAL OR HORTICULTURAL USE | KUMIAI CHEMICAL INDUSTRY CO., LTD. (JP) | 2008-12-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090042917-A1 | Aminopyrimidine Derivative and Plant Disease Control Agent for Agricultural or Horticultural Use | DPYD, PM20D2, PDCD11 | ADORA2A 608/4885LMNA 4597/4885HTT 1033/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.